These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Approaches targeting the FGF-FGFR system: a review of the recent patent literature and associated advanced therapeutic agents. Herbert C; Lassalle G; Alcouffe C; Bono F Pharm Pat Anal; 2014; 3(6):585-612. PubMed ID: 25489913 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms. Auguste P; Gürsel DB; Lemière S; Reimers D; Cuevas P; Carceller F; Di Santo JP; Bikfalvi A Cancer Res; 2001 Feb; 61(4):1717-26. PubMed ID: 11245488 [TBL] [Abstract][Full Text] [Related]
46. Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma. Massari F; Ciccarese C; Santoni M; Lopez-Beltran A; Scarpelli M; Montironi R; Cheng L Expert Rev Anticancer Ther; 2015; 15(12):1367-9. PubMed ID: 26568023 [TBL] [Abstract][Full Text] [Related]
47. FGFR-TKI resistance in cancer: current status and perspectives. Yue S; Li Y; Chen X; Wang J; Li M; Chen Y; Wu D J Hematol Oncol; 2021 Feb; 14(1):23. PubMed ID: 33568192 [TBL] [Abstract][Full Text] [Related]
48. Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis. Oladipupo SS; Smith C; Santeford A; Park C; Sene A; Wiley LA; Osei-Owusu P; Hsu J; Zapata N; Liu F; Nakamura R; Lavine KJ; Blumer KJ; Choi K; Apte RS; Ornitz DM Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13379-84. PubMed ID: 25139991 [TBL] [Abstract][Full Text] [Related]
49. Disruption of fibroblast growth factor receptor signaling in bovine cumulus-oocyte complexes during in vitro maturation reduces subsequent embryonic development. Zhang K; Ealy AD Domest Anim Endocrinol; 2012 May; 42(4):230-8. PubMed ID: 22264662 [TBL] [Abstract][Full Text] [Related]
50. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy. Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652 [TBL] [Abstract][Full Text] [Related]
51. Antiangiogenic activity of a neutralizing human single-chain antibody fragment against fibroblast growth factor receptor 1. Ronca R; Benzoni P; Leali D; Urbinati C; Belleri M; Corsini M; Alessi P; Coltrini D; Calza S; Presta M; Dell'Era P Mol Cancer Ther; 2010 Dec; 9(12):3244-53. PubMed ID: 20940322 [TBL] [Abstract][Full Text] [Related]
52. Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins. Koziczak M; Holbro T; Hynes NE Oncogene; 2004 Apr; 23(20):3501-8. PubMed ID: 15116089 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application. Chae YK; Ranganath K; Hammerman PS; Vaklavas C; Mohindra N; Kalyan A; Matsangou M; Costa R; Carneiro B; Villaflor VM; Cristofanilli M; Giles FJ Oncotarget; 2017 Feb; 8(9):16052-16074. PubMed ID: 28030802 [TBL] [Abstract][Full Text] [Related]
54. Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. Dell'Era P; Ronca R; Coco L; Nicoli S; Metra M; Presta M Circ Res; 2003 Sep; 93(5):414-20. PubMed ID: 12893744 [TBL] [Abstract][Full Text] [Related]
55. FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma. Tamburello M; Altieri B; Sbiera I; Sigala S; Berruti A; Fassnacht M; Sbiera S Endocrine; 2022 Sep; 77(3):411-418. PubMed ID: 35583844 [TBL] [Abstract][Full Text] [Related]
56. Fibroblast growth factors, fibroblast growth factor receptors, diseases, and drugs. Chen GJ; Forough R Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):211-24. PubMed ID: 18221087 [TBL] [Abstract][Full Text] [Related]
57. Differential distribution of fibroblast growth factor receptors (FGFRs) on foveal cones: FGFR-4 is an early marker of cone photoreceptors. Cornish EE; Natoli RC; Hendrickson A; Provis JM Mol Vis; 2004 Jan; 10():1-14. PubMed ID: 14737068 [TBL] [Abstract][Full Text] [Related]
58. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer. Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992 [TBL] [Abstract][Full Text] [Related]
59. Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerations. Ho HK; Yeo AH; Kang TS; Chua BT Drug Discov Today; 2014 Jan; 19(1):51-62. PubMed ID: 23932951 [TBL] [Abstract][Full Text] [Related]